Medical store raided in Burail, illicit drugs seized

The drug control wing of the UT Health Department conducted a raid at a medical store in Burail yesterday and seized illicit drugs in huge quantity.

A joint team, led by Tajinder Singh and Amit Lakhanpal, drugs inspectors of the Chandigarh Administration, swooped down at M/s Burail Medicos (previously Singh Medicos) located in Ekta Market, Burail, Sector 45.

During the raid, the team found seven types of habit-forming drug, totaling 3,334 capsules and 630 tablets of tramadol, tepantadol and pregabalin – 300mg. The market value of the seized drugs, based on the MRP, is approximately Rs 90,000. The team observed that the establishment neither maintained purchase and sale records nor possessed the mandatory Schedule H1 register.

The raid resulted in the seizure of the illicit drugs, which would be presented before the Chief Judicial Magistrate, Chandigarh. A show-cause notice highlighting the observed discrepancies and violations of the Drugs and Cosmetics Act, 1940, was served on the chemist shop by the Drugs Controller-cum-Licensing Authority.

Officials said the action was part of an ongoing effort to curb unethical practices in the sale, stocking and supply of drugs prone to misuse. The Health Department warned all parties concerned against engaging in such activities, emphasising that strict action would be taken against the violators of the Drugs and Cosmetics Act/Rules.

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session